LGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions,…
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its Phase…
Read More...
Read More...